OneMedNet Corp — Director's Dealing 2025

Nov 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OneMedNet Corp (ONMD)
CIK: 0001849380
Period of Report: 2023-12-08

Reporting Person: Yu Jeffrey (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-08	Common Stock	P	3300	$1.31	Acquired	2458424	Direct
2023-12-11	Common Stock	P	30	$1.36	Acquired	2458454	Direct
2023-12-12	Common Stock	P	3040	$1.06	Acquired	2461494	Direct
2023-12-13	Common Stock	P	50	$1.09	Acquired	2461544	Direct
2023-12-15	Common Stock	P	10	$0.92	Acquired	2461554	Direct
2023-12-27	Common Stock	P	10	$1.03	Acquired	2461564	Direct
2024-01-02	Common Stock	P	20	$0.82	Acquired	2461584	Direct
2024-01-04	Common Stock	P	180	$0.84	Acquired	2461764	Direct
2024-01-08	Common Stock	P	10	$0.83	Acquired	2461774	Direct
2024-01-09	Common Stock	P	100	$0.86	Acquired	2461874	Direct
2024-01-10	Common Stock	P	20	$0.85	Acquired	2461894	Direct
2024-01-12	Common Stock	P	20	$0.81	Acquired	2461914	Direct
2024-01-16	Common Stock	P	15	$0.75	Acquired	2461929	Direct
2024-01-17	Common Stock	P	362	$0.61	Acquired	2462291	Direct
2024-01-19	Common Stock	P	60	$0.48	Acquired	2462351	Direct
2024-01-19	Common Stock	A	45000	$0.00	Acquired	2507351	Direct
2024-01-22	Common Stock	P	5035	$0.49	Acquired	2512386	Direct
2024-01-23	Common Stock	P	720	$0.52	Acquired	2513106	Direct
2024-01-24	Common Stock	P	740	$0.55	Acquired	2513846	Direct
2024-01-25	Common Stock	P	2304	$0.55	Acquired	2516150	Direct
2024-01-26	Common Stock	P	5386	$0.56	Acquired	2521536	Direct
2024-01-29	Common Stock	P	950	$1.04	Acquired	2522486	Direct
2024-01-30	Common Stock	P	400	$1.14	Acquired	2522886	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1311970	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.28 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report.

F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.35 to $1.37, inclusive.

F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.09, inclusive.

F4: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.82 to $0.85, inclusive.

F5: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.78, inclusive.

F6: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.56 to $0.73, inclusive.

F7: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive.

F8: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive.

F9: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.48 to $0.54, inclusive.

F10: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.52 to $0.60, inclusive.

F11: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.50 to $0.60, inclusive.

F12: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.51 to $0.60, inclusive.

F13: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.07, inclusive.

F14: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.48, inclusive.

F15: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024.

F16: The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.